Find Clinical Drug Pipeline Developments & Deals for CAS-58-46-8

CAS-58-46-8
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check all USDMF suppliers

Contact Us
PharmaScopic.com

CAS-58-46-8

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 15 USDMF, 1 JDMF, 7 EU WC, 10 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

42 FDF Dossiers, 23 FDA Orange Book, 11 Europe, 4 Canada, 4 Australia

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 SPI Pharma, 3 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 ACG Worldwide, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 4 Gangwal Chemicals, 3 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 8 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

34 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 19 Lubricants & Glidants, 19 Direct Compression, 16 Granulation, 14 Disintegrants & Superdisintegrants, 12 Controlled & Modified Release, 7 Thickeners and Stabilizers, 7 Chewable & Orodispersible Aids, 5 Co-Processed Excipients, 5 Taste Masking, 5 Empty Capsules, 4 Film Formers & Plasticizers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Parenteral, 1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

4 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 Others

4 Others

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Dr. Reddy's Laboratories

India

CPhI WW Frankfurt

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Lead Product(s) : Tetrabenazine

Therapeutic Area : Undisclosed

Study Phase : Phase I

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 11, 2018

Lead Product(s) : Tetrabenazine

Therapeutic Area : Undisclosed

Highest Development Status : Phase I

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Dr Reddy Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

Dr. Reddy's Laboratories

India

CPhI WW Frankfurt

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Lead Product(s) : Tetrabenazine

Therapeutic Area : Undisclosed

Study Phase : Phase I

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 04, 2018

Lead Product(s) : Tetrabenazine

Therapeutic Area : Undisclosed

Highest Development Status : Phase I

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Dr Reddy Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

William Ondo, MD

Country

Peptide Process CMC

Not Confirmed

04

Bausch Health

Canada

Peptide Process CMC

Not Confirmed